ASTRAZEN — Astrazeneca Pharma India Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Astrazeneca Pharma India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,485	5,003	5,056	5,361	4,574
Net Total Accounts Receivable
Net Total Receivables	1,050	1,325	1,854	2,398	2,137
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7,057	8,355	9,327	13,424	17,322
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	767	702	648	636	1,175
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	8,566	9,849	10,780	15,181	19,891
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,327	3,839	3,571	7,030	9,818
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	3,452	3,962	3,661	7,478	11,163
Common Stock
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity	5,114	5,887	7,119	7,704	8,728
Total Liabilities & Shareholders' Equity	8,566	9,849	10,780	15,181	19,891
Total Common Shares Outstanding